"Sequential triple-T" therapy for CLL - 101793

Spotlight
Video

"Sequential triple-T" therapy for CLL

VJHemOnc has 922 videos Subscribe Here

Loading........
Description: “Sequential triple-T” therapy is a regimen consisting of tailored and targeted treatment aiming for total eradication of minimal residual disease (MRD). Here, Barbara Eichhorst, MD, of the University Hospital Cologne, Cologne, Germany, provides an overview of the Phase II CLL2-BIO study (NCT02689141) of bendamustine, ofatumumab and ibrutinib in treatment-naïve and relapsed/refractory chronic lymphocytic leukemia (CLL) patients. Dr Eichhorst highlights the promising results of this sequential regimen. This interview was recorded at the American Society of Hematology (ASH) 2017 Annual Meeting and Exposition in Atlanta, GA.
Shared By : VJHemOnc
Posted on : 02/05/18
Added : 15 days ago



Recommended

Nothing found.

More From VJHemOnc

Nothing found.